326 related articles for article (PubMed ID: 35738680)
21. Is there new hope for therapeutic matrix metalloproteinase inhibition?
Vandenbroucke RE; Libert C
Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinase inhibitors: a patent review (2011 - 2013).
Li NG; Tang YP; Duan JA; Shi ZH
Expert Opin Ther Pat; 2014 Sep; 24(9):1039-52. PubMed ID: 25098768
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinases and cancer - roles in threat and therapy.
Yadav L; Puri N; Rastogi V; Satpute P; Ahmad R; Kaur G
Asian Pac J Cancer Prev; 2014; 15(3):1085-91. PubMed ID: 24606423
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.
Mondal S; Adhikari N; Banerjee S; Amin SA; Jha T
Eur J Med Chem; 2020 May; 194():112260. PubMed ID: 32224379
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
Craig VJ; Zhang L; Hagood JS; Owen CA
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.
Verma RP; Hansch C
Bioorg Med Chem; 2007 Mar; 15(6):2223-68. PubMed ID: 17275314
[TBL] [Abstract][Full Text] [Related]
27. Structure-based molecular insights into matrix metalloproteinase inhibitors in cancer treatments.
Lin H; Xu P; Huang M
Future Med Chem; 2022 Jan; 14(1):35-51. PubMed ID: 34779649
[TBL] [Abstract][Full Text] [Related]
28. Molecular and clinical insights of matrix metalloproteinases into cancer spread and potential therapeutic interventions.
Siddhartha R; Garg M
Toxicol Appl Pharmacol; 2021 Sep; 426():115593. PubMed ID: 34038713
[TBL] [Abstract][Full Text] [Related]
29. Multifunctional intracellular matrix metalloproteinases: implications in disease.
Bassiouni W; Ali MAM; Schulz R
FEBS J; 2021 Dec; 288(24):7162-7182. PubMed ID: 33405316
[TBL] [Abstract][Full Text] [Related]
30. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Liu J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
[TBL] [Abstract][Full Text] [Related]
32. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
Karagiannis ED; Popel AS
J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
[TBL] [Abstract][Full Text] [Related]
33. Matrix Metalloproteinases: A challenging paradigm of cancer management.
Alaseem A; Alhazzani K; Dondapati P; Alobid S; Bishayee A; Rathinavelu A
Semin Cancer Biol; 2019 Jun; 56():100-115. PubMed ID: 29155240
[TBL] [Abstract][Full Text] [Related]
34. The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer.
He L; Kang Q; Chan KI; Zhang Y; Zhong Z; Tan W
Front Immunol; 2022; 13():1093990. PubMed ID: 36776395
[TBL] [Abstract][Full Text] [Related]
35. The Roles of Matrix Metalloproteinases in Pancreatic Cancer.
Knapinska AM; Estrada CA; Fields GB
Prog Mol Biol Transl Sci; 2017; 148():339-354. PubMed ID: 28662827
[TBL] [Abstract][Full Text] [Related]
36. Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer.
Piperigkou Z; Manou D; Karamanou K; Theocharis AD
Methods Mol Biol; 2018; 1731():325-348. PubMed ID: 29318564
[TBL] [Abstract][Full Text] [Related]
37. Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions.
Mittal R; Patel AP; Debs LH; Nguyen D; Patel K; Grati M; Mittal J; Yan D; Chapagain P; Liu XZ
J Cell Physiol; 2016 Dec; 231(12):2599-621. PubMed ID: 27187048
[TBL] [Abstract][Full Text] [Related]
38. Metalloproteinases and metalloproteinase inhibitors in age-related diseases.
Gargiulo S; Gamba P; Poli G; Leonarduzzi G
Curr Pharm Des; 2014; 20(18):2993-3018. PubMed ID: 24079771
[TBL] [Abstract][Full Text] [Related]
39. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.
Cabral-Pacheco GA; Garza-Veloz I; Castruita-De la Rosa C; Ramirez-Acuña JM; Perez-Romero BA; Guerrero-Rodriguez JF; Martinez-Avila N; Martinez-Fierro ML
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419373
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications.
Li YY; Feldman AM
Drugs; 2001; 61(9):1239-52. PubMed ID: 11511020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
